z-logo
open-access-imgOpen Access
Ibrutinib + Cirmtuzumab in Patients With CLL/SLL or Mantle Cell Lymphoma
Author(s) -
Richard Simoneaux
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000658712.96226.34
Subject(s) - mantle cell lymphoma , ibrutinib , chronic lymphocytic leukemia , medicine , cancer research , lymphoma , bruton's tyrosine kinase , oncology , tyrosine kinase , leukemia , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom